Title: Silent Brain Infarcts in Patients with Non-Specific Neurological Symptoms: 1-Year Cross-Sectional Study

Authors: Dr Sasnaka Pakalapati, Dr Prakash Babaliche

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i1.130

Abstract

Background: Silent brain infarctions are considered as a preclinical warning of symptomatic strokes and multiple deep infarct-relatedbrain damage.Limitation of studies on risk factors and non-specific neurological symptoms in the Indian population led to the formulation of the present study.

Aim: To evaluate the presence of silent brain infarctions in patients with non-specific neurological symptoms and association with cardiovascular risk factors.

Methods: This cross-sectional study was conducted from January to December 2010, including patients with non-specific neurological symptoms (n = 51). General and neurological assessment with Mini-Mental Scale Examination were conducted after recording the demographic data, body mass index, and cardiovascular risk factors. T2-weighted magnetic resonance imaging was performed with repetition time of 4500 ms and echo time of 116 ms. Scans were processed with double-blind method. Particle-enhanced turbidimetric immunoassay technique was performed for assessing high-sensitivity C-reactive protein.

Results: The major non-specific neurological symptoms were headache (54.90%), dizziness (23.53%),and vertigo (25.49%). Out of 51 patients, 29.41% were diagnosed with silent brain infarction. Cortical (26.6%) and sub cortical (73.4%) nature of infarction was recorded. The association of risk factors with silent brain infarction was not significant.

Conclusion: Patients with non-specific neurological symptoms should be examined for silent brain infarction. Follow-up study can be conducted with large sample size to evaluate the association of the risk factors with infarction and stroke.

Keywords: Silent brain infarction; high-sensitivity C-reactive protein; MRI.

References

  1. Feng C, Bai X, Xu Y, Hua T, Liu X-Y.The ‘silence’ of silent brain infarctions may be related to chronic ischemic precondit-ioning and nonstrategic locations rather than to a small infarction size. Clinics (Sao Paulo) 2013: 68(3):365–369.
  2. Das RR, Seshadri S, Beiser AS, Kelly-Hayes M, Au R, Himali JJ, Kase CS, Benjamin EJ, Polak JF, O'Donnell CJ, Yoshita M, D'Agostino RB Sr, DeCarli C, Wolf PA. Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke 2008: 39(11):2929–2935.
  3. Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H, Hori M. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 2005: 36(4):768-772.
  4. Hougaku H, Matumoto M, Irino T, Hashimoto H, Handa N, Takenobu K. Non-specific neurological complaints and silent cerebral infarction. Nihon Ronen Igakkai Zasshi 1996: 33(6):460-464.
  5. Gaist D, Garde E, Blaabjerg M, Nielsen HH, Kroigard T, Østergaard K, Møller HS, Hjelmborg J, Madsen CG, Iversen P, Kyvik KO, Siebner HR, Ashina M. Migraine with aura and risk of silent brain infarcts and white matter hyperintensities: an MRI study. Brain 2016: 139(Pt 7):2015-2023.
  6. Sarchielli P, Nardi K, Chiasserini D,Eusebi P, Tantucci M, Piero VD, Altieri M, Marini C, Russo T, Silvestrini M, Paolino I, Calabresi P, Parnetti L. Immunological profile of silent brain infarction and lacunar stroke.PLoS One 2013: 8(7):e68428.
  7. Fanning JP, Wong AA, Fraser JF.The epidemiology of silent brain infarction: a systematic review of population-based cohorts.BMC Med 2014: 12:119.
  8. Dick JP, Guiloff RJ, Stewart A, Blackstock J, Bielawska C, Paul EA, Marsden CD. Mini-mental state examination in neurological patients. J Neurol Neurosurg Psychiatry. 1984: 47(5):496-499.
  9. Chiu YH, Wu SC, Tseng CD, Yen MF, Chen TH. Progression of pre-hypertension, stage 1 and 2 hypertension (JNC 7): a population-based study in Keelung, Taiwan (Keelung Community-based Integrated Screening No. 9).J Hypertens 2006: 24(5):821-828.
  10. Alberti KG, Zimmet P, Shaw J.Metabolic syndrome--a new world-wide definition. A consensus statement from the International Diabetes Federation.Diabet Med 2006;23(5):469-480.
  11. Jih J, Mukherjea A, Vittinghoff E, Nguyen TT, Tsoh JY, Fukuoka Y, Bender MS, Tseng W, Kanaya AM. Using appropriate body mass index cut points for overweight and obesity among Asian Americans.Prev Med 2014: 65:1-6.
  12. Vermeer SE, Longstreth WT Jr, Koudstaal PJ.Silent brain infarcts: a systematic review.Lancet Neurol. 2007: (7):611-619.
  13. Fujishima M, Yao H, Terashi A, Taqawa K, Matsumoto M, Hara H, Akiguchi I, Suzuki K, Nishimaru K, Udaka F, Gyoten T, Takeuchi J, Hamada R, Yoshida Y, Ibayashi S.Deep white matter lesions on MRI, and not silent brain infarcts are related to headache and dizziness of non-specific cause in non-stroke Japanese subjects. Intern Med 2000: 39(9):727-731.
  14. Kobayashi S.Depressive state and silent vascular brain lesions. Intern Med 2000: 39(9):679-680.
  15. Chang CC, Chang WN, Huang CR, Liou CW, Lin TK, Lu CH. The relationship between isolated dizziness/vertigo and the risk factors of ischemic stroke: a case control study. Acta Neurol Taiwan 2011: 20(2):101-106.
  16. Kruit MC, Thijs RD, Ferrari MD, et al. Syncope and orthostatic intolerance increase risk of brain lesions in migraineurs and controls. Neurology 2013;80(21):1958-1965.
  17. Scher AI, Gudmundsson LS, Sigurdsson S, et al. Migraine headache in middle age and late-life brain infarcts. JAMA 2009;301(24):2563-2570.
  18. Kanzaki T, Uju Y, Sekine K, Ishii Y, Yoshimi T, Yasui R, Yasukawa A, Sato M, Okamoto S, Hisaoka T, Miura M, Kusanishi S, Murakami K, Nakano C, Mizuta Y, Mimori S, Mishima S, Igarashi K, Takizawa T, Hayakawa T, Tsukada K. Increased silent brain infarction accompanied with high prevalence of diabetes and dyslipidemia in psychiatric inpatients: a cross-sectional study.Prim Care Companion CNS Disord 2015: 17(2).
  19. Kato T, Inoue T, Yamagishi S, Morooka T, Okimoto T, Node K. Low-density lipoprotein subfractions and the prevalence of silent lacunar infarction in subjects with essential hypertension. Hypertension research 2006: 29(5):303-7.
  20. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 2005: 112(6):900-5.
  21. Umemura T, Kawamura T, Sakakibara T, Kanai A, Sano T, Hotta N, Sobue G. Association of soluble adhesion molecule and c-reactive protein levels with silent brain infarction in patients with and without type 2 diabetes. Curr Neurovasc Res 2008: 5(2):106-11.

Corresponding Author

Dr Prakash Babaliche

Associate Professor, Department of Medicine, KLE University's Jawaharlal Nehru Medical College,

Nehru Nagar, Belgaum 590010, Karnataka. India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Tel: +919343635679